Intrathecal gadolinium-enhanced MR myelography and cisternography: A pilot study in human patients

American Journal of Roentgenology

Volumn 173, Issue 4, 1999, Pages 1109-1115

  Zeng, Qingyu ^a   Xiong, Lin ^b   Jinkins, J Randy ^b   Fan, Zhanming ^a   Liu, Zhongsheng ^a  

^a China   (China)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; BEHAVIOR; CEREBROSPINAL FLUID; CISTERNOGRAPHY; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; FEMALE; HUMAN; INTERVERTEBRAL DISK HERNIA; MALE; MYELITIS; MYELOGRAPHY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; SUBARACHNOID SPACE; VERTEBRAL CANAL STENOSIS;

EID: 0032847186     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.173.4.10511188     Document Type: Article

References (17)

1. Niendorf HP, Haustein J, Cornelius I, Alhassan A, Claub W. Safety of gadolinium-DTPA: extended clinical experience. Magn Reson Med 1991;22: 222-228
2. Niendorf HP, Haustein J, Louton T, Beck W, Laniado M. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA: results of a randomized, controlled clinical trial. Invest Radiol 1991;26[suppl 1]:S221-S223
3. Goldstein HA, Kashanian FK, Blumetti RF, Holyoak WL, Hugo FP, Blumenfield DM. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials. Radiology 1990;174:17-23
4. Di Chiro G, Knop RH, Girton ME, et al. MR cisternography and myelography with Gd-DTPA in monkeys. Radiology 1985;157:373-377
5. Allard M, Kien P, Caille JM, Bonnemain B, Simonnet G. Brain distribution of MRI contrast media in rats after intracisternal injection. J Neuroradiol 1987;14:383-387
6. Ray DE, Cavanagh JB, Nolan CC, Williams SCR. Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats. Am J Neuroradiol 1996;17:365-373
7. Skalpe IO, Tang GJ. Magnetic resonance imaging contrast media in the subarachnoid space: a comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs. Invest Radiol 1997;32:140-148
8. Ray DE, Holton JL, Nolan CC, Cavanagh JB, Harpur ES. Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. Am J Neuroradiol 1998;19:1455-1462
9. Skalpe IO. Is it dangerous to inject MR contrast media into the subarachnoid space (letter)? Acta Radiol 1998;39:100
10. Jinkins JR, Williams RF, Xiong L. Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model: preliminary report. Invest Radiol 1999;34:156-159
11. Siebner HR, Grafin von Einsiedel H, Conrad B. Magnetic resonance ventriculography with gadolinium DTPA: report of two cases. Neuroradiology 1997;39:418-422
12. Tardy B, Guy C, Barral G, Page Y, Ollagnier M, Bertrand JC. Anaphylactic shock induced by intravenous gadopentetate dimeglumine (letter). Lancet 1992;339:494
13. Harbury OL. Generalized seizure after IV administration of gadopentetate dimeglumine. Am J Neuroradiol 1991;12:666
14. Tishler S, Hoffman JC Jr. Anaphylactoid reactions to IV gadopentetate dimeglumine. Am J Neuroradiol 1990;11:1167
15. Elster AD, Sobol WT, Hinson WH. Pseudolayering of Gd-DTPA in the urinary bladder. Radiology 1990;174:379-381
16. Di Chiro G, Girton ME, Frank JA, et al. Cerebrospinal fluid rhinorrhea: depiction with MR cisternography in dogs. Radiology 1986;160:221-222
17. Rosen GM, Griffeth LK, Brown MA, Drayer BP. Intrathecal administration of nitroxides as potential contrast agents for MR imaging. Radiology 1987;163:239-243